0001493152-20-010816.txt : 20200608 0001493152-20-010816.hdr.sgml : 20200608 20200608212131 ACCESSION NUMBER: 0001493152-20-010816 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200606 FILED AS OF DATE: 20200608 DATE AS OF CHANGE: 20200608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lotz Christopher L. CENTRAL INDEX KEY: 0001812553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 20950770 MAIL ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: SUITE B CITY: CARLSBAD STATE: CA ZIP: 90211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 BUSINESS PHONE: (760) 918-9165 MAIL ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 FORMER COMPANY: FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090402 4 1 ownership.xml X0306 4 2020-06-06 0 0001460702 Qualigen Therapeutics, Inc. QLGN 0001812553 Lotz Christopher L. C/O QUALIGEN THERAPEUTICS, INC., 2042 CORTE DEL NOGAL CARLSBAD CA 90211 0 1 0 0 Vice President of Finance, CFO Stock Option (Right to Buy) 5.13 2020-06-06 4 A 0 600000 0 A 2030-06-06 Common Stock 600000 600000 D Shares underlying the stock option vest over three years in equal annual installments from the date of grant. Hayden Trubitt, Attorney-in-Fact for Christopher L. Lotz 2020-06-08